AmplifyBio will advance the quality of human health and save lives by creating next-generation platforms, tools, and services to amplify and accelerate the development of therapies and vaccines that will be accessible to millions of people.
AmplifyBio spun out from Battelle in 2021 as a preclinical CRO with decades of experience designing and delivering in vivo safety, efficacy, and toxicology studies for the preparation of IND packages. Since its launch, AmplifyBio has steadily expanded services to support the discovery, characterization, optimization, and manufacturing of a broader range of drug modalities and become the industry’s preferred advanced therapy development and commercialization partner. Working with AmplifyBio reduces timelines and mitigates risks at every stage by integrating the right expertise, assay technologies, and data solutions.
Partner with the AmplifyBio team if you need a preclinical CRO or commercialization partner for any drug type.
Contact us today for questions or more information about our resources and expertise.
